| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |